These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 6544812

  • 1. Bone and liver images in medullary carcinoma of the thyroid gland: concise communication.
    Johnson DG, Coleman RE, McCook TA, Dale JK, Wells SA.
    J Nucl Med; 1984 Apr; 25(4):419-22. PubMed ID: 6544812
    [Abstract] [Full Text] [Related]

  • 2. Radionuclide liver and bone scanning in the evaluation of patients with endometrial carcinoma.
    Mettler FA, Christie JH, Garcia JF, Baldwin MH, Wicks JD, Bartow SA.
    Radiology; 1981 Dec; 141(3):777-80. PubMed ID: 6272356
    [Abstract] [Full Text] [Related]

  • 3. Tc-99m-(V)-DMSA: the new sensitive and specific radiopharmaceutical for imaging metastases of medullary thyroid carcinomas?
    Becker W, Börner W, Reiners C.
    Horm Metab Res Suppl; 1989 Dec; 21():38-42. PubMed ID: 2553574
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of bone and liver scans in surveying patients with breast cancer for metastatic disease.
    Evans DM, Wright DJ.
    Am Surg; 1987 Oct; 53(10):603-5. PubMed ID: 2823653
    [Abstract] [Full Text] [Related]

  • 10. Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma.
    Manil L, Boudet F, Motte P, Gardet P, Saccavini JC, Lumbroso JD, Schlumberger M, Caillou B, Bazin JP, Ricard M.
    Cancer Res; 1989 Oct 01; 49(19):5480-5. PubMed ID: 2766309
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
    Ohta H, Endo K, Fujita T, Koizumi M, Konishi J, Maki A, Mori K, Ozawa K, Inoue G, Nakano Y.
    J Nucl Med; 1988 Jun 01; 29(6):1130-5. PubMed ID: 2897436
    [Abstract] [Full Text] [Related]

  • 13. A new imaging agent for medullary carcinoma of the thyroid.
    Ohta H, Yamamoto K, Endo K, Mori T, Hamanaka D, Shimazu A, Ikekubo K, Makimoto K, Iida Y, Konishi J.
    J Nucl Med; 1984 Mar 01; 25(3):323-5. PubMed ID: 6321700
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Atypical uptake of 99m Tc-HMDP in a patient with metastatic liver disease.
    Moya Espinosa P, Amrani Raissouni T, Ramos Moreno E, Martínez del Valle Torres MD, Ortega Lozano SJ, Jiménez-Hoyuela García JM.
    Rev Esp Med Nucl Imagen Mol; 2012 Mar 01; 31(6):350-1. PubMed ID: 23169390
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.